NUSAP1 and hepatocellular carcinoma: For instance, in liver cancer patients, decreased expression of miR-193a-5p, miR-122, and miR-18b results in elevated NUSAP1 levels, which in turn promotes the proliferation of hepatocellular carcinoma cells (97–99).